Clinical Trial Update: Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan [Phase 1]

View source ↗

Summary

Astellas-sponsored Phase 1 single- and multiple-dose study in Japanese patients with hyperphosphatemia undergoing hemodialysis (in the context of chronic kidney…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Kidney Disease, Hyperphosphatemia Undergoing Hemodialysis | Phase 1 | Status: COMPLETED